Home › Ulcerative Colitis › Texas
Ulcerative Colitis clinical trials in Texas
33 studies for Ulcerative Colitis are looking for participants at sites in Texas.
Cities in Texas
- Houston17 studies
- San Antonio16 studies
- Tyler15 studies
- Lewisville10 studies
- Lubbock9 studies
- Garland8 studies
- Round Rock8 studies
- Dallas8 studies
- Fort Worth7 studies
- League City6 studies
- The Woodlands5 studies
- Arlington4 studies
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- and 10 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT07697456Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT03816345Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- and 3 more
RecruitingPhase 3
All ages · All sexes · Updated Oct 2, 2026 · NCT06651281A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- and 3 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 30, 2026 · NCT06598943A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- and 7 more
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Texas - Southwestern Medical Center /ID# 271835, Dallas
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Sep 30, 2026 · NCT07071519Confirmatory Clinical Study in Active Ulcerative Colitis
- Southern Star Research Institute, San Antonio
RecruitingPhase 2
Ages 16 and older · All sexes · Updated Sep 30, 2026 · NCT07296315A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- and 4 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07845487A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- and 2 more
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT07012395Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- and 8 more
RecruitingPhase 1/2Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Sep 29, 2026 · NCT06619990A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Victorium Clinical Research, Houston
- and 3 more
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 25, 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Sep 25, 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0103, Fort Worth
- Texas Children's Hospital, Houston
RecruitingPhase 2/3
Ages 2 to 17 · All sexes · Updated Sep 24, 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937086LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Fort Worth, Fort Worth
- GI Alliance - Garland, Garland
- Integrity Advanced Therapeutics, Houston
- and 4 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07415044A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
RecruitingPhase 3
Ages 2 to 19 · All sexes · Updated Sep 22, 2026 · NCT04844606A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07483073LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Texas Digestive Disease Consultants - Cedar Park, Cedar Park
- GI Alliance - Dallas - Gaston Avenue, Dallas
- GI Alliance - Fort Worth, Fort Worth
- and 5 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07186101A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- GI Alliance - Digestive Health Associates of Texas, Dallas
- The University of Texas Health Science Center at Houston, Houston
- GI Alliance - Mansfield, Mansfield
- and 4 more
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 21, 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
- Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
- and 1 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Sep 15, 2026 · NCT07185009A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT04372108A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT07577856A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Texas Digestive Disease Consultants, Cedar Park
- Baylor College of Medicine, Houston
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 21, 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research - Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
- Valley Institute of Research - Site Number: 8400004, Harlingen
- and 7 more
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Aug 20, 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
Recruiting
Ages 18 and older · All sexes · Updated Aug 7, 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
Recruiting
Ages 18 to 85 · All sexes · Updated Aug 6, 2026 · NCT06571669An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
- Brooke Army Medical center, San Antonio
- and 2 more
RecruitingObservational study
Ages 18 to 64 · All sexes · Updated Jul 9, 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- ACT-Midwest G1, Abilene
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Jul 8, 2026 · NCT05287126A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated May 22, 2026 · NCT06764615Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 20, 2026 · NCT04751396A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
RecruitingPhase 3
Ages 2 and older · All sexes · Updated May 7, 2026 · NCT05442567A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- and 5 more
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
RecruitingObservational study
Ages 18 to 100 · All sexes · Updated May 18, 2021 · NCT04617184From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.